Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹31 Cr.
Stock P/E
-3.3
P/B
18.5
Current Price
₹20.4
Book Value
₹ 1.1
Face Value
10
52W High
₹31.8
52W Low
₹ 16.1
Dividend Yield
0%

Vadivarhe Speciality Overview

Business

Vadivarhe Speciality Chemicals Ltd. (VSCL) is engaged in the manufacturing and supply of speciality chemicals. Its core business model revolves around developing, producing, and distributing chemicals that provide specific performance attributes or functionalities for various industrial applications. The company operates primarily in a Business-to-Business (B2B) model, selling its products as critical intermediates or additives to customers in diverse end-user industries. VSCL generates revenue through the sale of these manufactured speciality chemical products.

Revenue Mix

Without specific company data, the exact breakdown of major business segments or revenue contribution is not available. However, typical speciality chemical companies often segment their business by end-use application (e.g., agrochemicals, pharmaceuticals, personal care, textiles, construction, industrial additives) or by chemical type (e.g., intermediates, performance chemicals, polymers). It is likely that VSCL's revenue is derived from a portfolio of products catering to one or more of these specialized areas.

Industry

The Indian chemicals industry is diverse, with the speciality chemicals segment being highly dynamic, innovation-driven, and fragmented, featuring a mix of large diversified players, mid-sized niche specialists, and smaller regional manufacturers. It is characterized by product differentiation, technical service, and often long-term customer relationships. VSCL, as a speciality chemicals player, likely positions itself by focusing on specific product chemistries, offering customized solutions, maintaining product quality, and potentially achieving cost-effectiveness in its chosen niches. Its positioning would be relative to both larger domestic and international competitors, as well as smaller domestic peers in specific product lines.

MOAT

For a speciality chemicals company like VSCL, potential competitive advantages often include:

Switching Costs: If its products are critical inputs integrated into customer formulations or processes, switching suppliers can be complex, costly, and time-consuming due to re-testing, regulatory approvals, and potential production disruptions.

Proprietary Formulations/Technical Expertise: Development of unique or difficult-to-replicate chemical formulations, processes, or application know-how.

Customer Relationships & Service: Deep technical collaboration with customers, offering tailored solutions and strong after-sales support, leading to embedded relationships.

Regulatory Compliance Expertise: Ability to meet stringent quality and regulatory standards required by specific end-user industries (e.g., pharmaceuticals, food additives).

Without specific details, the extent and durability of these advantages for VSCL cannot be definitively assessed.

Growth Drivers

Key factors that could drive growth for VSCL over the next 3-5 years include:

Growth in End-User Industries: Increased demand from client sectors such as pharmaceuticals, agrochemicals, automotive, construction, or personal care products, which are consumers of speciality chemicals.

Import Substitution: Government initiatives and industry trends favoring domestic manufacturing ("Make in India") could lead to increased demand for locally produced speciality chemicals.

New Product Development: Successful R&D leading to the introduction of new, high-value-added products or applications addressing evolving industry needs.

Capacity Expansion: Investment in expanding manufacturing capacities to meet growing demand or capture new market share.

Export Opportunities: Leveraging competitive manufacturing costs and product quality to cater to international markets, especially in regions with high demand for specific chemicals.

Risks

Raw Material Price Volatility: Fluctuations in the cost of key feedstocks, often derived from crude oil or other basic chemicals, can impact profit margins.

Intense Competition: The speciality chemicals sector is competitive, facing pressure from larger global players and agile domestic competitors, potentially leading to pricing pressures.

Environmental & Regulatory Risks: Strict environmental protection regulations can lead to higher compliance costs, operational restrictions, or potential penalties.

Technological Obsolescence: Continuous innovation is required; failure to keep pace with new technologies or product developments could erode market share.

Demand Cyclicality: Performance can be linked to the economic cycles and health of the end-user industries it serves.

Foreign Exchange Fluctuations: For companies involved in significant imports of raw materials or exports of finished goods, currency volatility can impact profitability.

Management & Ownership

As is common with many Indian companies, VSCL is likely promoter-driven, meaning the founding family or individuals hold a significant stake and play a key role in management. While specific details about the promoters' background or the management team's experience are not available, their strategic vision, operational efficiency, and commitment to R&D and customer relationships would be crucial for the company's long-term success. The ownership structure typically involves promoter holdings, institutional investors, and public shareholders.

Outlook

VSCL operates within the dynamic Indian speciality chemicals sector, which generally benefits from underlying industrial growth and government impetus for domestic manufacturing. The bull case for VSCL rests on its ability to leverage its technical expertise, develop a robust product pipeline, deepen customer relationships, and expand capacity effectively to capitalize on demand from its end-user industries. Growth in these sectors, coupled with potential import substitution opportunities, could drive revenue and profitability.

Conversely, the bear case highlights significant industry challenges. VSCL faces risks from volatile raw material costs, intense competition, and stringent regulatory environments. The company's ability to maintain a competitive edge through innovation and cost management will be crucial. A failure to adapt to changing market demands, manage operational risks, or effectively pass on cost increases to customers could negatively impact its financial performance. The outlook remains balanced, contingent on the company's execution capabilities in a challenging yet growing industry landscape.

Vadivarhe Speciality Share Price

Live · NSE · Inception: 2009
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Vadivarhe Speciality Quarterly Results

#(Fig in Cr.) Mar 2018 Jun 2018 Sep 2018 Dec 2018 Jun 2019 Dec 2019 Jun 2020 Dec 2020 Jun 2021 Dec 2021
Net Sales 6 8 6 12 11 5 7 4 4 6
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 6 8 6 12 11 5 7 4 4 6
Total Expenditure 5 6 6 11 10 8 7 5 5 8
Operating Profit 1 1 1 1 1 -3 0 -0 -1 -2
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses -0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 1 0 0 0 -4 -1 -1 -2 -3
Provision for Tax 0 0 -0 0 -0 1 0 0 0 0
Profit After Tax 0 1 0 0 0 -5 -1 -1 -2 -3
Adjustments -0 -1 -0 0 0 0 0 0 -0 0
Profit After Adjustments 0 0 0 0 0 -5 -1 -1 -2 -3
Adjusted Earnings Per Share 0 0.5 0.1 0.2 0.1 -3.8 -0.6 -0.7 -1.5 -2.3

Vadivarhe Speciality Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 19 26 35 26 32 30 26 21 44 40 38 21
Other Income 0 0 0 0 0 0 0 1 1 1 0 0
Total Income 19 26 35 26 33 30 27 22 45 41 38 21
Total Expenditure 12 19 25 22 30 39 27 28 41 36 44 25
Operating Profit 8 8 11 4 3 -9 -0 -6 4 5 -6 -3
Interest 1 1 1 1 1 1 1 2 2 2 2 0
Depreciation 1 1 1 1 2 2 2 2 2 2 2 0
Exceptional Income / Expenses 0 0 1 0 0 0 1 0 0 0 0 0
Profit Before Tax 6 5 9 2 0 -12 -3 -10 1 2 -9 -7
Provision for Tax 2 2 3 0 -0 -2 0 0 0 1 0 0
Profit After Tax 4 3 6 2 0 -10 -3 -10 1 0 -9 -7
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 4 3 6 2 0 -10 -3 -10 1 0 -9 -7
Adjusted Earnings Per Share 0 0 0 1.4 0 -7.7 -2.2 -7.5 0.9 0 -7.2 -5.1

Vadivarhe Speciality Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 15 18 23 27 27 18 15 5 6 6 -3
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 8 5 4 4 13 10 15 16 16 19 23
Other Non-Current Liabilities -1 1 3 3 3 1 1 1 0 0 0
Total Current Liabilities 6 9 15 9 15 23 17 20 23 16 22
Total Liabilities 28 34 46 44 58 51 47 42 46 42 43
Fixed Assets 15 15 17 20 26 25 26 24 23 22 22
Other Non-Current Assets 6 7 7 8 8 5 2 3 3 2 0
Total Current Assets 8 13 22 16 23 21 19 14 20 18 20
Total Assets 28 34 46 44 58 51 47 42 46 42 43

Vadivarhe Speciality Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 1 0 0 1 1 1 1 1 1 1
Cash Flow from Operating Activities 5 4 2 7 -1 4 -0 1 -0 2 -7
Cash Flow from Investing Activities -0 -1 -4 -5 -8 -2 0 -1 -1 -1 -1
Cash Flow from Financing Activities -4 -4 2 -1 9 -2 1 -1 1 -2 9
Net Cash Inflow / Outflow 1 -1 -0 1 -0 0 0 -0 0 -0 0
Closing Cash & Cash Equivalent 1 0 0 1 1 1 1 1 1 1 1

Vadivarhe Speciality Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0 0 0 1.38 0.05 -7.7 -2.16 -7.52 0.9 0.05 -7.25
CEPS(Rs) 4.19 3.65 5.91 2.38 1.32 -6.33 -0.75 -6.12 2.3 1.41 -5.8
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 0 0 0 21.46 21.5 13.81 11.65 4.13 5.03 5.08 -2.17
Core EBITDA Margin(%) 38.36 26.47 28.33 14.56 7.18 -30.66 -2.33 -32.29 7.02 11.03 -16.11
EBIT Margin(%) 33.33 23.28 28.08 11.37 3.6 -35.21 -4.82 -36.9 6.3 8.32 -19.9
Pre Tax Margin(%) 28.79 18.95 25.76 8.39 0.16 -39.76 -9.79 -44.79 2.63 3.76 -24.44
PAT Margin (%) 20.29 12.1 16.37 6.82 0.19 -32.64 -10.43 -44.79 2.63 0.15 -24.44
Cash Profit Margin (%) 25.86 15.8 19.47 11.74 5.22 -26.84 -3.6 -36.45 6.72 4.48 -19.57
ROA(%) 13.61 10.81 15.07 3.93 0.12 -18.04 -5.6 -21.62 2.6 0.14 -21.97
ROE(%) 31.7 20.84 29.06 6.94 0.23 -43.6 -16.97 -95.27 19.6 0.95 -499.06
ROCE(%) 24.36 23.24 31.84 8.03 2.72 -24.74 -3.37 -23.27 8.73 10.1 -22.89
Receivable days 82.24 79.53 118.25 168.78 120.2 126.36 119.14 94.74 32.57 48.78 63.57
Inventory Days 26.56 23.92 21.9 35.76 54.62 81.32 70.16 86.49 64.34 78.12 88.1
Payable days 108.05 60.71 92.79 162.94 128.06 150.19 212.87 190.97 135.23 150.19 96.51
PER(x) 0 0 0 61.27 762.89 0 0 0 30.7 644.49 0
Price/Book(x) 0 0 0 3.95 1.72 0.47 1.08 6.05 5.48 6.11 -12.09
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.86 0.57 0.71 4.58 2.09 0.9 1.46 2.59 1.4 1.63 1.82
EV/Core EBITDA(x) 2.14 1.99 2.3 28.19 24.25 -3.03 -173.89 -8.71 14.71 12.88 -11.99
Net Sales Growth(%) 37.15 38.13 33.28 -27.03 26.6 -6.85 -12.18 -18.97 103.64 -8.25 -5.42
EBIT Growth(%) 467.42 -0.48 58.57 -71.47 -60.42 -1011.56 87.99 -520.87 134.79 21.08 -326.27
PAT Growth(%) 5347.26 -15.04 77.91 -70.62 -96.49 0 71.94 -248.05 111.94 -94.64 0
EPS Growth(%) 0 0 0 0 -96.49 0 71.94 -248.05 111.94 -94.64 0
Debt/Equity(x) 0.89 0.59 0.54 0.35 0.76 1.11 1.57 4.62 4.19 4.03 -12.98
Current Ratio(x) 1.28 1.37 1.4 1.72 1.58 0.92 1.11 0.72 0.87 1.14 0.9
Quick Ratio(x) 1.08 1.11 1.27 1.39 1.13 0.62 0.91 0.38 0.5 0.6 0.46
Interest Cover(x) 7.34 5.38 12.1 3.81 1.05 -7.74 -0.97 -4.68 1.71 1.82 -4.38
Total Debt/Mcap(x) 0 0 0 0.09 0.44 2.39 1.46 0.76 0.76 0.66 1.07

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -5% +22% +5% +7%
Operating Profit CAGR -220% — — 0%
PAT CAGR — — — 0%
Share Price CAGR -27% -21% -8% —
ROE Average -499% -160% -118% -50%
ROCE Average -23% -1% -6% +3%

Vadivarhe Speciality Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 71.73 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 28.27 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 74.6474.6469.9566.8366.8366.8366.8366.8366.8371.73
FII 0000000000
DII 0000000000
Public 25.3625.3630.0533.1733.1733.1733.1733.1733.1728.27
Others 0000000000
Total 100100100100100100100100100100

Vadivarhe Speciality Peer Comparison

Chemicals Edit Columns

Vadivarhe Speciality Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Vadivarhe Speciality Pros & Cons

Pros

  • Debtor days have improved from 150.19 to 96.51days.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of -160% over the last 3 years.
  • Stock is trading at 18.5 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp